CORONARY ARTERY DISEASE, cilt.23, ss.39-44, 2012 (SCI İndekslerine Giren Dergi)
Background There are limited data on prognostic value of gamma-glutamyltransferase (GGT) in acute coronary syndromes (ACS) with non-ST-segment elevation (NSTE-ACS). We investigated GGT levels and their association with significant stenosis and major cardiac events (MACE) in NSTE-ACS patients.